| Sexual Dysfunction in Female |
1 |
1 |
| Contraception |
0 |
0.9 |
| Erectile Dysfunction |
0 |
0.76 |
| Testosterone |
0 |
0.62 |
| Low Testosterone |
0 |
0.49 |
| Pain Management |
0 |
0.49 |
| Sexual Dysfunction |
0 |
0.47 |
| Sexual Dysfunction in Male |
0 |
0.39 |
| Pregnancy |
0 |
0.35 |
| Brain |
0 |
0.23 |
| Medical Education |
0 |
0.23 |
| Hypogonadism |
0 |
0.2 |
| Adolescent Medicine |
0 |
0.16 |
| Child |
0 |
0.16 |
| Hand |
0 |
0.16 |
| Off-Label Use |
0 |
0.16 |
| Phimosis |
0 |
0.16 |
| Sexuality |
0 |
0.16 |
| Sterilization, Birth Control |
0 |
0.11 |
| Alabama |
0 |
0.08 |
| Alcohol Use |
0 |
0.08 |
| Anatomy |
0 |
0.08 |
| Birth |
0 |
0.08 |
| Emesis |
0 |
0.08 |
| Endocrinology |
0 |
0.08 |
| Epidemiology |
0 |
0.08 |
| Food and Drug Administration (FDA) |
0 |
0.08 |
| Grant |
0 |
0.08 |
| Hospital |
0 |
0.08 |
| Pain |
0 |
0.08 |
| Penis |
0 |
0.08 |
| Physiology |
0 |
0.08 |
| Pituitary Gland |
0 |
0.08 |
| Plasma |
0 |
0.08 |
| Platelet Count |
0 |
0.08 |
| Primary Care |
0 |
0.08 |
| Psychotropic Drugs |
0 |
0.08 |
| Sexual Health |
0 |
0.99 |
| Sleep |
0 |
0.08 |